MedTrace Logo

SARS CoV-2 Infection and Inflammatory Biomarkers

NCT05145751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2022-03-02

No results posted yet for this study

Summary

Early research suggests that inflammation plays a key role in the development of SARS CoV-2 infection. The immune response to respiratory infection is characterized by an influx of neutrophils to the lungs. This study ought to investigate the association of simple biomarkers such as NLR and PLR with the clinical outcome in SARS CoV-2 infection patients.

Conditions

Interventions

OTHER

Simple inflammatory biomarkers measurement

In patients with polymerase chain reaction (PCR) confirmed SARS CoV-2 infection the values of simple inflammatory biomarkers such NLR will be measured

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Eleni Arnaoutoglou, M.D., Ph.D. · Study Chair

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-10-01
Completion
2022-01-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05145751 on ClinicalTrials.gov